» Articles » PMID: 29901179

Nrf2 Protects Against Diabetic Dysfunction of Endothelial Progenitor Cells Via Regulating Cell Senescence

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2018 Jun 15
PMID 29901179
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is associated with an increased risk of cardiovascular disease. A decrease in the number and functionality of endothelial progenitor cells (EPCs) leads to reduced endothelial repair and the development of cardiovascular disease. The aim of the present study was to explore the effect and underlying mechanisms of nuclear factor erythroid 2‑related factor 2 (Nrf2) on EPC dysfunction caused by diabetic mellitus. The biological functions of EPCs in streptozotocin‑induced diabetic mice were evaluated, including migration, proliferation, angiogenesis and the secretion of vascular endothelial growth factor (VEGF), stromal‑derived growth factor (SDF) and nitric oxide (NO). Oxidative stress levels in diabetic EPCs were also assessed by detecting intracellular reactive oxygen species (ROS), superoxide dismutase (SOD) and malondialdehyde (MDA). EPC senescence was evaluated by measuring p16 and b‑gal expression and observing the senescence‑associated secretory phenotype. In addition, the function of EPCs and level of oxidative stress were assessed following Nrf2 silencing or activation. Nrf2 silencing resulted in a decrease of EPC biological functions, accelerated cell senescence and increased oxidative stress, as indicated by ROS and MDA upregulation accompanied with decreased SOD activity. Furthermore, Nrf2 silencing inhibited migration, proliferation and secretion in EPCs, while it increased oxidative stress and cell senescence. Nrf2 activation protected diabetic EPCs against the effects of oxidative stress and cell senescence, ameliorating the biological dysfunction of EPCs derived from mice with diabetes. In conclusion, Nrf2 overexpression protected against oxidative stress‑induced functional damage in EPCs derived from diabetic mice by regulating cell senescence.

Citing Articles

Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2.

Buttari B, Tramutola A, Rojo A, Chondrogianni N, Saha S, Berry A Biomolecules. 2025; 15(1).

PMID: 39858508 PMC: 11764413. DOI: 10.3390/biom15010113.


Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies.

Vahidinia Z, Azami Tameh A, Barati S, Izadpanah M, Hosseini E Cell Mol Biol Lett. 2024; 29(1):30.

PMID: 38431569 PMC: 10909300. DOI: 10.1186/s11658-024-00551-3.


Ginseng-Sanqi-Chuanxiong (GSC) extracts attenuate d-galactose-induced vascular aging in mice via inhibition of endothelial progenitor cells senescence.

Liu Y, Liu Y, Wang X, Xiu C, Hu Y, Wang J Heliyon. 2024; 10(4):e25253.

PMID: 38404901 PMC: 10884806. DOI: 10.1016/j.heliyon.2024.e25253.


Targeting the redox system for cardiovascular regeneration in aging.

Allemann M, Lee P, Beer J, Saeedi Saravi S Aging Cell. 2023; 22(12):e14020.

PMID: 37957823 PMC: 10726899. DOI: 10.1111/acel.14020.


Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice.

Heng Y, Shang H, Zhang X, Wei W BMC Cardiovasc Disord. 2023; 23(1):446.

PMID: 37697234 PMC: 10494373. DOI: 10.1186/s12872-023-03485-4.


References
1.
Zampetaki A, Kirton J, Xu Q . Vascular repair by endothelial progenitor cells. Cardiovasc Res. 2008; 78(3):413-21. DOI: 10.1093/cvr/cvn081. View

2.
Bhatwadekar A, Shaw L, Grant M . Promise of endothelial progenitor cell for treatment of diabetic retinopathy. Expert Rev Endocrinol Metab. 2013; 5(1):29-37. PMC: 3652409. DOI: 10.1586/eem.09.75. View

3.
Cantrell D . T cell antigen receptor signal transduction pathways. Annu Rev Immunol. 1996; 14:259-74. DOI: 10.1146/annurev.immunol.14.1.259. View

4.
Li W, Hu N, Lei F, Wei S, Rong J, Zhuang H . Autophagy inhibits endothelial progenitor cells migration via the regulation of MMP2, MMP9 and uPA under normoxia condition. Biochem Biophys Res Commun. 2015; 466(3):376-80. DOI: 10.1016/j.bbrc.2015.09.031. View

5.
Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y . An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236(2):313-22. DOI: 10.1006/bbrc.1997.6943. View